Abstract:Variable-temperature NMR experiments and ab initio density functional calculations were carried out to investigate the conformation interconversion of novel chiral 3-alkyl-3,4-dihydro-2H-benzo[1,4]oxazine derivatives. With CDCl3 as the solvent, the coalescence temperatures of H-2, H-3, H-11 and H-19 of product 1 are about 289, 304, 292, and 316 K, with the corresponding activation free energies at 58.0 +/- 6.7, 60.9 +/- 7.1, 58.3 +/- 6.8, and 59.6 +/- 6.9 kJ(.)mol(-1), respectively. When dimethyl sulfoxide (DMSO-d(6)) was used as the solvent, H-1 and C-13 NMR signals were completely assigned at 375 K. The effects of solvent and temperature were investigated through a polarizable continuum model. At each theoretical level (MP2 or B3LYP), the changing tendencies of the calculated activation free energies and interconversion rates agree well with those of the NMR results. In addition, the interconversion rate at each specified temperature was calculated to be about 1.5 times faster in DMSO-d6 than in CDCl3. Accordingly, we failed to observe the coalescence phenomena of H-3 and H-19 in DMSO-d(6) by NMR measurements from 296 to 375 K. The substitution effect at the R-1-R-5 positions was considered using density functional calculations, with the activation barriers decreasing as follows: product 6 > 3 > 1 > 7 > 2. This sequence is consistent with that of the reaction heats, except for product 7, implying that the interconversion processes may be thermodynamically controlled. Surprisingly, the substituted groups near the acetyl group in product 2 and 7 do not elevate the activation barrier but, instead, lower it somewhat, with the possible reasons for this provided in the paper.

Theoretical Conformational Analysis of 1,5-Benzodiazepines and Benzothiazepines

Synthesis and conformational analysis of new derivatives of 7-chloro-1,3-dihydro-5-phenyl-2h-1,4-benzodiazepine-2-one

Cycloaddition of Benzoheteroazepine Ii - Reactions and Conformations of Cycloadducts on 1,5-Benzothiazepines and 1,5-Benzodiazepines with Nitrile Imine and Nitrile Oxides

Structure and Conformational Analysis of 5,5-Bis(bromomethyl)- 2-(4-chlorophenyl)-2-methyl-1,3-dioxane

Study on Conformation Interconversion of 3-Alkyl-4-acetyl-3;4-dihydro-2h-1;4-benzoxazines from Dynamic NMR Experiments and Ab Initio Density Functional Calculations

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

Synthesis and conformational aspects of 2-phenoxytetralones: Experimental verification and density functional theory (DFT) calculation

1H NMR STUDY ON THE STEREOCHEMISTRY OF 1,3-OXAZINO[3,2-D][1,5] BENZODIAZEPINE-1-ONES

Mass Spectrometric Studies of Cis- and Trans-1a,3-Disubstituted-1,1-Dichloro-4-Formyl-1a, 2,3,4-Tetrahydro-1h-azirino [1,2-A] [1,5]Benzodiazepines

Molecular Machanics Study on the Conformation of 4, 4 '-Dibenzoylbiphenyl

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

2-Dipentylamino-4-(4-methoxybenzyl-idene)-1-phenyl-1H-imidazol-5(4H)-one

Theoretical and NMR Investigations on the Conformations of ( − )-Meptazinol Hydrochloride in Solution

The mass spectral fragmentation of 1a,3-disubstituted 4-benzoyl-1a,2,3,4- tetrahydrooxazirino[2,3-a][1,5]benzodiazepines

On the Mechanism and Stereochemistry of the Formation of Β‐lactam Derivatives of 2,4‐Disubstituted‐2,3‐dihydro‐benzo[1,4]diazepines

Mass Spectral Fragmentation of Cis- and Trans-1A,3-disubstituted 1, 1-Dichloro-1a,2,3,4-tetrahydro-1h-azirino[1,2-a] [1, 5]Benzodiazepines.

1,3A,5-Triphenyl-3a,4,5,6-tetrahydro-1,2,4-oxadiazolo[4,5-a][1,5]benzodiazepine

Crystal Structure Of 1,1-Dichloro-4-Formyl-3-Methyl-1a-Phenyl-1a,2,3,4-Tetrahydro-1h-Azirino[ 1,2-A][1,5]Benzodiazepine (C18h16cl2n2o)

Benzotriazepine synthesis, conformational analysis, and biological properties

Conformational Landscapes of 2,3-, 2,4-, 2,5-, and 2,6-Difluorobenzaldehyde Unveiled by Rotational Spectroscopy

Fast-Atom Bombardment Mass Spectrometric Studies of Trisubstituted 3A,4,5,11-Tetrahydro-1,2,4-oxadiazolo[5,4-d][1,5]benzothiazepines